CHAC1 and injury: And the remarkable alleviation in the cell apoptosis and inflammation after Botch overexpression, suggesting that therapies targeting Notch1 hold significant promise for the treatment and prevention of pathologic processes characterized by ICH-induced brain injury, and Botch might be good target for improving SBI after ICH.